$HSTM

REBROVICK LINDA sold $50K of HSTM

REBROVICK LINDA sold 2,000 shares of HEALTHSTREAM INC (HSTM) at $25.00 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · REBROVICK LINDA
Published Jun 2, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HSTM
Neutral
medium confidence
Mentioned
$HSTM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

The only new information is the disclosed sale details (2,000 shares at $25.00, $50,000 total) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and modest transaction value reduce the signal strength.

03

What to watch

The filing does not disclose any new company-specific fundamentals, and the post-transaction holdings (54,181 shares) suggest the director remains a meaningful holder.

Relevance 2/10Novelty 3/10Timing: SEC Form 4 filed 2026-06-02 for a 2026-06-01 sale

Background

The article is an SEC Form 4 insider transaction disclosure for HealthStream (HSTM) by director Linda Rebrovick.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream director Linda Rebrovick sold 2,000 shares in an open-market transaction on 2026-06-01 under a 10b5-1 plan, totaling $50,000.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the disclosed sale size is relatively small versus typical large-cap trading flows.

Market effects

No clear sector read-through from a single, small 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • HEALTHSTREAM INC

    US-listed company whose director insider sale is disclosed via Form 4.

  • REBROVICK LINDA

    Director who sold 2,000 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles